Product
TTYP01
Aliases
Edaravone tablets
Name
edaravone
INN Name
Edaravone
FDA Approved
Yes
1 clinical trial
3 organizations
1 indication
1 document
Indication
Adult HealthClinical trial
A Phase 1, Randomized, Open-Label, Three-Treatment, Three-Period Crossover Study to Assess Bioequivalence and Safety of TTYP01 Tablets to Radicava® Injection, and Radicava ORS® in Healthy Adult Subjects Under Fasting ConditionsStatus: Completed, Estimated PCD: 2023-12-14
Document
DailyMed Label: edaravoneOrganization
Gland Pharma LimitedOrganization
Long Grove Pharmaceuticals, LLCOrganization
Piramal Critical Care Inc.